-
Spatially Patterned Kidney Assembloids Advance Disease Model
2026-05-25
Huang et al. introduce human kidney progenitor assembloids (hKPAs) that recapitulate self-assembly, spatial patterning, and physiological function of the kidney with unprecedented fidelity. This innovation establishes a new benchmark for in vivo kidney disease modeling and regenerative research.
-
Lysosomal β-Galactosidase Staining Kit: Precision in Senesce
2026-05-25
The Lysosomal β-Galactosidase Staining Kit delivers artifact-free, polystyrene-compatible lysosomal enzyme detection for robust control staining in senescence workflows. Leveraging new insights into chemoresistance mechanisms, it enables reproducible histochemical assays essential for oncology and aging studies.
-
FLOT1–FOSL2–EphA2 Axis Modulates Microglial Polarization in
2026-05-24
This study identifies the interaction between FLOT1 and FOSL2 as a crucial regulator of EphA2 expression, influencing microglial polarization and neuroinflammation in Alzheimer's disease. Targeting the FLOT1–FOSL2–EphA2 pathway may offer a new strategy to control pro-inflammatory microglial activation and preserve cognitive function in AD models.
-
Thiothixene: Bridging Antipsychotic Action and Efferocytosis
2026-05-23
Explore how thiothixene, a typical antipsychotic agent, is redefining translational research by uniting neuropharmacology with immunomodulation. This article offers mechanistic insights, evidence-based protocol guidance, and strategic considerations for leveraging thiothixene’s dual action—antagonizing dopamine signaling and enhancing macrophage efferocytosis—across neuropsychiatric and immunological research domains. We contextualize APExBIO’s thiothixene within this evolving landscape, outlining competitive advantages, experimental protocols, and the translational promise for disease-modifying therapies.
-
Pamidronate Enhances Osteogenesis of CPT-Derived MSCs via OP
2026-05-22
This study reveals that pamidronate disodium promotes proliferation and osteogenic differentiation in mesenchymal stem cells from congenital tibial pseudarthrosis (CPT) patients, acting through the OPG/RANKL signaling axis and MAPK pathways. These results clarify pamidronate's mechanism in CPT and offer new directions for targeted cell-based therapies.
-
Reserpine (N1867): Technical Protocols and Workflow Guidance
2026-05-22
Reserpine (SKU N1867) is a high-purity, research-grade alkaloid used in controlled neurotransmitter depletion and antihypertensive mechanism studies. This compound is not suitable for diagnostic or medical use, and long-term solution storage should be avoided to maintain consistency. Researchers benefit from clear workflow controls and technical parameters to ensure reliable experimental outcomes.
-
Thiothixene: A Typical Antipsychotic Agent Redefining In Vit
2026-05-21
Thiothixene stands apart as a typical antipsychotic agent that not only modulates central dopamine and serotonin signaling but also uniquely enhances macrophage efferocytosis through vitamin A pathway activation. Its robust pharmacokinetic profile—resistant to CYP2D6-mediated interactions—empowers both neuropharmacological research and advanced immunological assays.
-
Vitamin C (CAS 50-81-7): Mechanistic Insights for Organoid O
2026-05-21
Explore how Vitamin C (ascorbic acid) acts as an anticancer agent and apoptosis inducer in advanced organoid models. This article uniquely links mechanistic evidence to practical workflows—essential reading for cutting-edge cancer research.
-
Dabigatran and Evolving Strategies in Thromboembolism Preven
2026-05-20
The reference study details the clinical and pharmacological advances of dabigatran as a non-vitamin K oral anticoagulant, highlighting its advantages over warfarin for thromboembolic disorder management. Its predictable pharmacokinetics, rapid onset, and reduced monitoring needs mark a shift in atrial fibrillation stroke prevention and VTE therapy.
-
Strategic mRNA Tracking: Maximizing Translation and Immune E
2026-05-20
Explore how dual-reporter, 5-moUTP-modified mRNA technologies like EZ Cap™ Cy5 Firefly Luciferase mRNA empower translational researchers to optimize delivery, suppress innate immunity, and visualize transfection in real time. This article synthesizes cutting-edge mechanistic insight, recent advances in lipid-based delivery, and practical guidance on experimental design to set a new standard for mRNA research workflows.
-
Clasto-Lactacystin β-lactone: Precision Proteasome Inhibitio
2026-05-19
Clasto-Lactacystin β-lactone from APExBIO sets a new benchmark for irreversible, cell-permeable proteasome inhibition in advanced cellular assays. Its potent selectivity and workflow adaptability drive reproducible discoveries in ubiquitin-proteasome pathway research, viral immunology, and disease modeling.
-
Nebulized Risedronate Sodium Microspheres for Emphysema Ther
2026-05-19
This study introduces a nebulized Risedronate Sodium-chitosan microsphere system for targeted induction of alveolar macrophage apoptosis in pulmonary emphysema. The research provides evidence for deep lung deposition, low cytotoxicity, and significant attenuation of emphysema pathology, suggesting a promising inhaled therapy route for COPD-related lung damage.
-
Indazole/Indole Glucagon Receptor Antagonists for T2DM Contr
2026-05-18
This study reports the design and synthesis of novel indazole- and indole-based glucagon receptor antagonists, advancing the field of type 2 diabetes research. The lead compounds demonstrated potent in vitro and in vivo glucose-lowering effects, underlining the therapeutic promise of targeting the glucagon receptor for improved glycemic management.
-
Neuroligin 1 Proteolysis and Social Memory Maintenance Mecha
2026-05-18
This study uncovers how social interaction triggers α- and γ-secretase-dependent proteolysis of Neuroligin 1 in the ventral hippocampus, generating intracellular fragments essential for sustaining social memory. The work provides mechanistic insight into synaptic remodeling during memory maintenance and suggests novel intervention points for cognitive disorders.
-
NMDA (N-Methyl-D-aspartic acid): Reliable Modeling for CNS A
2026-05-17
This article addresses real-world laboratory challenges in excitotoxicity research and oxidative stress assays, demonstrating how NMDA (N-Methyl-D-aspartic acid) (SKU B1624) ensures reproducibility and data integrity. Evidence-backed scenarios illustrate why SKU B1624 is a trusted choice for cell viability and neurodegenerative disease modeling.